Letter: bismuth quadruple therapy with Pylera for H. pylori infection

被引：1
|
作者：
Molina-Infante, J. [1 ]
Gisbert, J. P. [2 ,3 ]
机构：
[1] Hosp San Pedro de Alcantara, Dept Gastroenterol, Caceres, Spain
[2] Hosp Univ Princesa, Dept Gastroenterol, Inst Invest Sanitaria Princesa IP, Madrid, Spain
[3] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 40卷 / 06期
关键词：
D O I：
10.1111/apt.12876
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：735 / 736
页数：2
相关论文
共 50 条
  • [1] Letter: bismuth quadruple therapy with Pylera for Helicobacter pylori infection - authors' reply
    Malfertheiner, P.
    Delchier, J. C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) : 736 - 737
  • [2] The exposure of antibiotics on the eradication of bismuth quadruple therapy in H. pylori infection
    聂尚姝
    [J]. China Medical Abstracts (Internal Medicine), 2022, (01) : 47 - 48
  • [3] Effectiveness and safety of bismuth quadruple therapy (Pylera®) in combination with PPIs for the eradication of H. pylori infection in patients with dual clarithromycin and metronidazole resistance
    Fiorini, G.
    Saracino, I. M.
    Gatta, L.
    Vaira, D.
    [J]. HELICOBACTER, 2017, 22
  • [4] Bismuth quadruple therapy for H pylori
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (01): : 9 - 9
  • [5] Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study
    Gravina, Antonietta G.
    Priadko, Kateryna
    Granata, Lucia
    Facchiano, Angela
    Scida, Giuseppe
    Cerbone, Rosa
    Ciamarra, Paola
    Romano, Marco
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Rescue therapy with bismuth quadruple regimen in patients with H. pylori resistant strains
    Fiorini, G.
    Saracino, I. M.
    Zullo, A.
    Gatta, L.
    Pavoni, M.
    Vaira, D.
    [J]. HELICOBACTER, 2018, 23
  • [7] Can two week bismuth based quadruple therapy for resistant H. pylori infection still be used in the UK?
    Logan, R. P.
    Logan-Ellis, H.
    Bensaid, L. P.
    [J]. HELICOBACTER, 2017, 22
  • [8] Bismuth quadruple regimen with tetracycline or doxycycline versus Pylera® as third-line rescue therapy for H. pylori infection: A prospective multicenter analysis of the European Registry on Helicobacter pylori Management (Hp-EuReg)
    Nyssen, O. P.
    Perez-Aisa, A.
    Rodrigo-Saez, L.
    Castro-Fernandez, M.
    Mata Romero, P.
    Ortuno, J.
    Barrio, J.
    Huguet, J.
    Modollel, I.
    Alcaide, N.
    Lucendo, A.
    Calvet, X.
    Perona, M.
    Gomez, B.
    Rodriguez, B. Gomez
    Varela, P.
    Jimenez-Moreno, M.
    Dominguez-Cajal, M.
    Pozzati, L.
    Burgos, D.
    Bujanda, L.
    Hinojosa, J.
    Molina-Infante, J.
    Di Maira, T.
    Ferrer, L.
    Fernandez-Salazar, L.
    Figuerola, A.
    Tito, L.
    de la Coba, C.
    Gomez-Camarero, J.
    Fernandez, N.
    Caldas, M.
    Garre, A.
    Resina, E.
    Espada, M.
    Puig, I.
    Megraud, F.
    O'Morain, C.
    Gisbert, J. P.
    [J]. HELICOBACTER, 2020, 25 : 24 - 25
  • [9] NON-BISMUTH QUADRUPLE "CONCOMITANT" THERAPY VERSUS STANDARD TRIPLE THERAPY FOR CLARITHROMYCIN-SUSCEPTIBLE H. PYLORI AND VERSUS QUADRUPLE "SEQUENTIAL" THERAPY FOR CLARITHROMYCIN-RESISTANT H. PYLORI
    Molina-Infante, J.
    Pazos-Pacheco, C.
    Vinagre-Rodriguez, G.
    Hernandez-Alonso, M.
    Martin-Noguerol, E.
    Gonzalez-Santiago, J. M.
    Duenas-Sadornil, C.
    Gonzalez-Garcia, G.
    Fernandez-Bermejo, M.
    Gisbert, J. P.
    [J]. HELICOBACTER, 2011, 16 : 135 - 136
  • [10] TL quadruple therapy is superior to AL quadruple therapy and AL triple therapy in the rescue treatment of H. pylori infection
    Hsu, Ping-I
    Tsai, Feng-Woei
    Wu, Deng-Chyang
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 364 - 364
12345